People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TYBR Health, Inc. | — | Biotechnology | Series A | $7.9M | $28.8M | 2025 |
Tom J. Dugan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tom J. Dugan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alex Smith | 1 | 5 |
| Timothy J. Keane | 1 | 2 |
| Timothy Keane | 1 | 2 |
| Alex J. Smith | 1 | 1 |
| Jeffrey J. Tyber | 1 | 1 |
| Timothy J. Keane, Jr. | 1 | 1 |
| Stephen J. Ramon | 1 | 1 |
| Cooper J. Collins | 1 | 1 |
| Tom Dugan | 1 | 1 |
| Toby J. Hamilton | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.